Hypothesis

Oura Ring’s peripheral temperature signal precedes measurable changes in heart‑rate variability (HRV) by 6–12 hours during the early phase of infection or physiological stress. Combining Oura’s temperature‑derived readiness trend with WHOOP’s strain/recovery algorithm will produce an earlier and more specific warning of impending illness than either device alone, without increasing user‑reported gamification stress.

Mechanistic Rationale

Peripheral skin temperature reflects vasomotor adjustments driven by hypothalamic set‑point shifts that occur as cytokines act on the thermoregulatory center before systemic autonomic imbalance manifests. HRV, meanwhile, indexes parasympathetic withdrawal that follows the inflammatory cascade. Because temperature leads HRV, a dual‑threshold model—temperature rise >0.2 °C above individual baseline and HRV drop >10 % from rolling median—should flag stress earlier than HRV‑only thresholds used by WHOOP.

Testable Predictions

1. In a longitudinal cohort, the combined temperature‑HRV alert will precede self‑reported symptom onset by a median of 8 hours, whereas WHOOP’s recovery score will fall only after symptom onset.
2. The combined alert will have higher specificity for true infectious episodes (confirmed by PCR or clinical diagnosis) than WHOOP’s low‑recovery flag, reducing false‑positive strain warnings.
3. Users receiving the combined alert will report lower perceived stress (measured by PSS‑10) than those receiving WHOOP‑only strain/recovery notifications, because the advice frames the signal as a health check rather than a performance push.

Study Design (Falsifiable)

• Participants: 120 recreational athletes (balanced sex, age 18‑35) recruited for 8‑week monitoring.
• Groups: (A) Oura only, (B) WHOOP only, (C) Combined algorithm (temperature‑HRV alert) displayed on a shared smartphone app.
• Procedures: Daily morning basal temperature, nocturnal HRV, sleep staging, and weekly wellness surveys. Participants log any illness symptoms and undergo rapid antigen testing when symptoms appear.
• Outcomes: Lead time (hours) between alert and first symptom, sensitivity/specificity of alerts for PCR‑confirmed illness, and changes in POMS and cortisol awakening response.
• Analysis: Mixed‑effects models with group as fixed effect, participant as random intercept. Falsification occurs if Group C does not show a statistically significant earlier lead time (≥4 hours) and equal or lower specificity compared to Group B.

Expected Implications

If confirmed, the hypothesis would suggest that integrating peripheral temperature trends into existing strain/recovery platforms can shift wearables from reactive performance coaching to proactive health guarding. This extends the current validation of Oura’s superior HRV/temperature accuracy Oura achieved 0.99 concordance correlation for HRV against Polar H10 ECG across 536 nights of home sleep monitoring and WHOOP’s athlete‑centric guidance WHOOP functions as an athlete‑focused strain/recovery coaching system with explicit green‑means‑push guidance, while addressing the open gap of limited RCT validation for recovery protocols across diverse populations there's limited RCT validation of specific recovery protocols across diverse populations including women and non-athletes. Failure to observe the predicted lead time or specificity advantage would refute the claim that temperature leads HRV in early stress responses, prompting reconsideration of multimodal alert design.